Mayobanex Pujols - 09 Feb 2026 Form 3 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role
Chief Technology Officer
Signature
/s/ Marc Grasso, as Attorney-in-Fact
Issuer symbol
KYTX
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
3
Filing time
11 Feb 2026, 16:30:27 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pujols Mayobanex Chief Technology Officer C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE /s/ Marc Grasso, as Attorney-in-Fact 11 Feb 2026 0002109086

No securities are beneficially owned.